New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases
Acta Pharmaceutica Sinica B
; (6): 91-104, 2020.
Article
em En
| WPRIM
| ID: wpr-781539
Biblioteca responsável:
WPRO
ABSTRACT
Cytochrome P450 1A (CYP1A), one of the major CYP subfamily in humans, not only metabolizes xenobiotics including clinical drugs and pollutants in the environment, but also mediates the biotransformation of important endogenous substances. In particular, some single nucleotide polymorphisms (SNPs) for genes may affect the metabolic ability of endogenous substances, leading to some physiological or pathological changes in humans. This review first summarizes the metabolism of endogenous substances by CYP1A, and then introduces the research progress of SNPs, especially the research related to human diseases. Finally, the relationship between SNPs and diseases is discussed. In addition, potential animal models for gene editing are summarized. In conclusion, CYP1A plays an important role in maintaining the health in the body.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Prognostic_studies
Idioma:
En
Revista:
Acta Pharmaceutica Sinica B
Ano de publicação:
2020
Tipo de documento:
Article